David Bennett - Ryman Healthcare Group Officer
| RYHTY Stock | USD 12.86 0.19 1.46% |
Executive
Mr. David Bennett is Chief Financial Officer of the Company. Dave joined Ryman in 2013 and was promoted to Chief Financial Officer in 2017. Dave has a Bachelor of Commerce degree and is a chartered accountant. Before joining Ryman, he worked as an accountant and auditor. since 2017.
| Tenure | 7 years |
| Phone | 64 3 366 4069 |
| Web | https://www.rymanhealthcare.co.nz |
David Bennett Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Bennett against Ryman Healthcare pink sheet is an integral part of due diligence when investing in Ryman Healthcare. David Bennett insider activity provides valuable insight into whether Ryman Healthcare is net buyers or sellers over its current business cycle. Note, Ryman Healthcare insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ryman Healthcare'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Bennett over a year ago Acquisition by David Bennett of 1000000 shares of Cerberus Cyber subject to Rule 16b-3 |
Ryman Healthcare Management Efficiency
Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jessica Kral | ModivCare | N/A | |
| Heather CPA | Acadia Healthcare | 52 | |
| Mark Palmenter | Acadia Healthcare | N/A | |
| MS DO | Encompass Health Corp | 64 | |
| Elissa Charbonneau | Encompass Health Corp | 64 | |
| Bill Priest | Acadia Healthcare | N/A | |
| RN BSN | Enhabit | 66 | |
| FACP MD | InnovAge Holding Corp | 57 | |
| Nasser MD | Acadia Healthcare | N/A | |
| Rauly Gutierrez | InnovAge Holding Corp | N/A | |
| Dylan Black | Enhabit | 54 | |
| William Zima | Concord Medical Services | N/A | |
| Benjamin Adams | InnovAge Holding Corp | 60 | |
| Bridget Sherick | Select Medical Holdings | N/A | |
| Mark Brewer | Enhabit | N/A | |
| Cara Babachicos | InnovAge Holding Corp | N/A | |
| Langham MBA | Enhabit | 47 | |
| Jing Zhang | Concord Medical Services | 49 | |
| Andrew Price | Encompass Health Corp | 57 | |
| Shelly Eckenroth | Select Medical Holdings | N/A | |
| Christine Bent | InnovAge Holding Corp | 53 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 |
Ryman Healthcare Leadership Team
Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claire Higgins, Non-Executive Independent Director | ||
| Anthony Leighs, Independent Director | ||
| Cameron Holland, Chief Australia | ||
| Richard Umbers, Group Exec | ||
| Gordon MacLeod, CFO, Deputy Chief Executive and Company Secretary | ||
| Kevin Hickman, Co-Founder, Director and Member of Remuneration and Nominations Committee | ||
| Taylor Allison, Design Manager | ||
| Michelle Perkins, IR Contact Officer | ||
| Simon Challies, CEO, Managing Director, Executive Director | ||
| Tom Brownrigg, Construction Manager | ||
| Jo Appleyard, Independent Non-Executive Director | ||
| Jenn Poskitt, Marketing Manager | ||
| Philip Mealings, Property and Purchasing Manager | ||
| George Savvides, Independent Director | ||
| Douglas McKay, Independent Director | ||
| Cheyne Chalmers, Chief Zealand | ||
| Debbie McClure, Group Sales Manager | ||
| Warren Bell, Independent Non-Executive Director | ||
| David Bennett, Group Officer | ||
| Deborah Marris, G Sec | ||
| Marsha Cadman, Chief Officer | ||
| Rick Davies, Chief Officer | ||
| Andrew Mitchell, Development Manager | ||
| David Kerr, Independent Non-Executive Chairman of the Board | ||
| Geoffrey Cumming, Director | ||
| MaryAnne Stone, Chief Officer | ||
| David King, Corporate Affairs Manager | ||
| Chris BE, Chief Officer | ||
| Barbara ReynenRose, Operations & Clinical Services Manager | ||
| Nicole Forster, Group Shared Services Manager |
Ryman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.91 B | |||
| Shares Outstanding | 100 M | |||
| Price To Earning | 10.13 X | |||
| Price To Book | 0.85 X | |||
| Price To Sales | 3.74 X | |||
| Revenue | 503.76 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryman Healthcare Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Ryman Pink Sheet analysis
When running Ryman Healthcare's price analysis, check to measure Ryman Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ryman Healthcare is operating at the current time. Most of Ryman Healthcare's value examination focuses on studying past and present price action to predict the probability of Ryman Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ryman Healthcare's price. Additionally, you may evaluate how the addition of Ryman Healthcare to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |